pindolol has been researched along with ajmaline in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doshchitsin, VL | 1 |
| Doshchitsin, VL; Fedorova, IF; Gendlin, GE; Pozin, VM; Skuratovskaia, SG | 1 |
| Addarii, F; Pretolani, E; Zoli, I | 1 |
| Topliss, JG; Yoshida, F | 1 |
4 other study(ies) available for pindolol and ajmaline
| Article | Year |
|---|---|
[Comparative evaluation of new drugs used in the treatment of cardiac arrhythmia].
Topics: Administration, Oral; Adrenergic beta-Antagonists; Ajmaline; Alprenolol; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Barbiturates; Drug Combinations; Drug Evaluation; Humans; Injections, Intramuscular; Injections, Intravenous; Lidocaine; Pindolol; Practolol; Propranolol; Sparteine; Verapamil | 1975 |
[Prevention of ventricular fibrillation in animal experiments].
Topics: Ajmaline; Animals; Anti-Arrhythmia Agents; Drug Evaluation; Lidocaine; Pindolol; Rats; Ventricular Fibrillation; Verapamil | 1978 |
[Pharmacological treatment associated with the insertion of a demand pacemaker in the atrial rhythm disease. Prearranged commentary on the report of Scardi and collaborators].
Topics: Ajmaline; Arrhythmias, Cardiac; Electrocardiography; Glucagon; Heart Block; Humans; Pacemaker, Artificial; Pindolol | 1973 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |